Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Multiple Myeloma trials
Trial of Oral Lenalidomide Stewardship Program for Veterans
Study Type: Interventional
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Study Type: Interventional Phase 1
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
Study Type: Interventional Phase 1
Connect® MM- The Multiple Myeloma Disease Registry
Study Type: Observational
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
Study Type: Interventional Phase 2
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
Study Type: Interventional
Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
Study Type: Interventional Phase 1
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation
Study Type: Interventional Phase 1
There are 515 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now